Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2-Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)-Reference-Cited by-同舟云学术

Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2-Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)

Published:2006-05-22 Issue:8 Volume:21 Page:1215-1223
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Eastell Richard,Hannon Rosemary A,Cuzick Jack,Dowsett Mitch,Clack Glen,Adams Judith E

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference35 articles.

1. Association between endogenous hormones and sex hormone-binding globulin and bone turnover in older women: Study of osteoporotic fractures;Chapurlat;Bone,2001

2. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study;Garnero;J Bone Miner Res,2000

3. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women;Rogers;J Clin Endocrinol Metab,2002

4. Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures;Ettinger;J Clin Endocrinol Metab,1998

5. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group;Cummings;N Engl J Med,1998

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of bisphosphonate and denosumab treatment on TBS in Japanese breast cancer patients with AIBL;Journal of Bone and Mineral Metabolism;2024-08-13

2. Endocrine consequences of breast cancer therapy and survivorship;Climacteric;2024-06-12

3. Review of bone health in women receiving endocrine therapy because of breast cancer;ORVOSI HETILAP;2024

4. Osteoporosis Awareness and Knowledge in Postmenopausal Breast Cancer Survivors;Turkish Journal of Osteoporosis;2024-04-01

5. Osteoporotic fracture risk in women with breast cancer treated with aromatase inhibitors: a health insurance claims database study in Japan;Expert Opinion on Pharmacotherapy;2024-02-11